TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Idexx Laboratories Sverige AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 13,259 | 12,511 | 10,645 |
Financial expenses | 0 | 1 | 7 |
Earnings before taxes | 191 | 253 | 227 |
EBITDA | 280 | 319 | 267 |
Total assets | 2,800 | 4,120 | 3,423 |
Current assets | 2,361 | 3,499 | 2,882 |
Current liabilities | 1,019 | 2,342 | 1,812 |
Equity capital | 1,782 | 1,779 | 1,611 |
- share capital | 4 | 5 | 5 |
Employees (average) | 17 | 17 | 18 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 63.6% | 43.2% | 47.1% |
Turnover per employee | 780 | 736 | 591 |
Profit as a percentage of turnover | 1.4% | 2.0% | 2.1% |
Return on assets (ROA) | 6.8% | 6.2% | 6.8% |
Current ratio | 231.7% | 149.4% | 159.1% |
Return on equity (ROE) | 10.7% | 14.2% | 14.1% |
Change turnover | 1,761 | 2,063 | 1,537 |
Change turnover % | 15% | 20% | 17% |
Chg. No. of employees | 0 | -1 | 1 |
Chg. No. of employees % | 0% | -6% | 6% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.